The Myeloma Beacon » Ridaforolimus (AP23573)

Ridaforolimus (AP23573)

By: Admin; Published: October 15, 2008 @ 8:00 am | Comments Disabled

Brand Name:
Generic Name:	ridaforolimus (formerly deforolimus)
Code Name:	AP23573
Company:	Ariad Pharmaceuticals & Merck
FDA Clinical Phase:	1

Description:

Ridaforolimus, formerly known as deforolimus, is a drug used to treat soft tissue and bone sarcomas. It is also being studied in the treatment of other solid tumors and hematologic cancer. Ridaforolimus may control the growth of blood vessels to the cancer. It belongs to the family of drugs called rapamycin analogs.

Clinical Trials:
For a list of clinical trials studying BI-505 for the treatment of multiple myeloma, see ClinicalTrials.gov ^[1].

Official website for Ridaforolimus: http://www.ariad.com/wt/tertiarypage/ridaforolimus ^[2]

Source: Wikipedia, ridaforolimus, http://en.wikipedia.org/wiki/Ridaforolimus ^[3] (as of November 14, 2009)

Article printed from The Myeloma Beacon: https://myelomabeacon.org

URL to article: https://myelomabeacon.org/resources/2008/10/15/deforolimus/

URLs in this post:

[1] ClinicalTrials.gov: http://www.clinicaltrial.gov/ct2/results?term=Ridaforolimus+or+AP23573&recr=&rslt=&type=&cond=multiple+myeloma&intr=&outc=&lead=&spons=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&rcv_s=&rcv_e=&lup_s=&lup_e=

[2] http://www.ariad.com/wt/tertiarypage/ridaforolimus: http://www.ariad.com/wt/tertiarypage/ridaforolimus

[3] http://en.wikipedia.org/wiki/Ridaforolimus: http://en.wikipedia.org/wiki/Ridaforolimus

Click here to print.